Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 49 articles:
HTML format



Single Articles


    January 2021
  1. MOCKUS TE, Munie A, Atkinson JR, Segal BM, et al
    Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal Models.
    J Immunol. 2021;206:3-10.
    PubMed     Abstract available


    October 2020
  2. TOSSBERG JT, Heinrich RM, Farley VM, Crooke PS 3rd, et al
    Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses.
    J Immunol. 2020 Oct 12. pii: jimmunol.2000384. doi: 10.4049/jimmunol.2000384.
    PubMed     Abstract available


    September 2020
  3. BARIK S, Cattin-Roy AN, Ukah TK, Miller MM, et al
    Type II Cytokines Fine-Tune Thymic T Cell Selection to Offset Murine Central Nervous System Autoimmunity.
    J Immunol. 2020 Sep 11. pii: jimmunol.2000614. doi: 10.4049/jimmunol.2000614.
    PubMed     Abstract available


    August 2020
  4. FINLAY CM, Cunningham KT, Doyle B, Mills KHG, et al
    IL-33-Stimulated Murine Mast Cells Polarize Alternatively Activated Macrophages, Which Suppress T Cells That Mediate Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2020 Aug 28. pii: jimmunol.1901321. doi: 10.4049/jimmunol.1901321.
    PubMed     Abstract available


    July 2020
  5. CLARKE J, Yaqubi M, Futhey NC, Sedaghat S, et al
    Vitamin D Regulates MerTK-Dependent Phagocytosis in Human Myeloid Cells.
    J Immunol. 2020;205:398-406.
    PubMed     Abstract available


  6. RIJVERS L, Melief MJ, van Langelaar J, van der Vuurst de Vries RM, et al
    The Role of Autoimmunity-Related Gene CLEC16A in the B Cell Receptor-Mediated HLA Class II Pathway.
    J Immunol. 2020 Jul 8. pii: jimmunol.1901409. doi: 10.4049/jimmunol.1901409.
    PubMed     Abstract available


    June 2020
  7. LI Z, He C, Zhang J, Zhang H, et al
    P2Y6 Deficiency Enhances Dendritic Cell-Mediated Th1/Th17 Differentiation and Aggravates Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2020 Jun 17. pii: jimmunol.1900916. doi: 10.4049/jimmunol.1900916.
    PubMed     Abstract available


  8. BOYDEN AW, Brate AA, Stephens LM, Karandikar NJ, et al
    Immune Autoregulatory CD8 T Cells Require IFN-gamma Responsiveness to Optimally Suppress Central Nervous System Autoimmunity.
    J Immunol. 2020 Jun 12. pii: jimmunol.2000211. doi: 10.4049/jimmunol.2000211.
    PubMed     Abstract available


    February 2020
  9. HUBER JE, Chang Y, Meinl I, Kumpfel T, et al
    Fingolimod Profoundly Reduces Frequencies and Alters Subset Composition of Circulating T Follicular Helper Cells in Multiple Sclerosis Patients.
    J Immunol. 2020 Feb 7. pii: jimmunol.1900955. doi: 10.4049/jimmunol.1900955.
    PubMed     Abstract available


    December 2019
  10. YOSHIMURA S, Thome R, Konno S, Mari ER, et al
    IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
    J Immunol. 2019 Dec 18. pii: jimmunol.1801113. doi: 10.4049/jimmunol.1801113.
    PubMed     Abstract available


    September 2019
  11. KAUSHANSKY N, Bakos E, Becker-Herman S, Shachar I, et al
    Circulating Picomolar Levels of CCL2 Downregulate Ongoing Chronic Experimental Autoimmune Encephalomyelitis by Induction of Regulatory Mechanisms.
    J Immunol. 2019 Sep 4. pii: jimmunol.1900424. doi: 10.4049/jimmunol.1900424.
    PubMed     Abstract available


    August 2019
  12. COLAMATTEO A, Maggioli E, Azevedo Loiola R, Hamid Sheikh M, et al
    Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients.
    J Immunol. 2019 Aug 28. pii: jimmunol.1801683. doi: 10.4049/jimmunol.1801683.
    PubMed     Abstract available


  13. ENGLER JB, Heckmann NF, Jager J, Gold SM, et al
    Pregnancy Enables Expansion of Disease-Specific Regulatory T Cells in an Animal Model of Multiple Sclerosis.
    J Immunol. 2019 Aug 23. pii: jimmunol.1900611. doi: 10.4049/jimmunol.1900611.
    PubMed     Abstract available


  14. FRAUSSEN J, Marquez S, Takata K, Beckers L, et al
    Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD(-)CD27(-) Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.
    J Immunol. 2019 Aug 7. pii: jimmunol.1801236. doi: 10.4049/jimmunol.1801236.
    PubMed     Abstract available


    July 2019
  15. ZHANG X, Kiapour N, Kapoor S, Khan T, et al
    IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2019 Jul 24. pii: jimmunol.1900311. doi: 10.4049/jimmunol.1900311.
    PubMed     Abstract available


  16. LINDAHL H, Guerreiro-Cacais AO, Bedri SK, Linnerbauer M, et al
    IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis.
    J Immunol. 2019 Jul 10. pii: jimmunol.1900400. doi: 10.4049/jimmunol.1900400.
    PubMed     Abstract available


    May 2019
  17. PIANCONE F, Saresella M, Marventano I, La Rosa F, et al
    A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis.
    J Immunol. 2019 May 29. pii: jimmunol.1801625. doi: 10.4049/jimmunol.1801625.
    PubMed     Abstract available


    March 2019
  18. GLATIGNY S, Hollbacher B, Motley SJ, Tan C, et al
    Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance.
    J Immunol. 2019;202:1373-1382.
    PubMed     Abstract available


    February 2019
  19. LI R, Rezk A, Ghadiri M, Luessi F, et al
    Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    J Immunol. 2019 Feb 15. pii: jimmunol.1900114. doi: 10.4049/jimmunol.1900114.
    PubMed    


    October 2018
  20. KAP YS, Bus-Spoor C, van Driel N, Dubbelaar ML, et al
    Targeted Diet Modification Reduces Multiple Sclerosis-like Disease in Adult Marmoset Monkeys from an Outbred Colony.
    J Immunol. 2018 Oct 19. pii: jimmunol.1800822. doi: 10.4049/jimmunol.1800822.
    PubMed     Abstract available


    July 2018
  21. WAN X, Pei W, Shahzad KA, Zhang L, et al
    A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4(+) and CD8(+) T Cells.
    J Immunol. 2018 Jul 9. pii: jimmunol.1800108. doi: 10.4049/jimmunol.1800108.
    PubMed     Abstract available


  22. GALICIA G, Lee DSW, Ramaglia V, Ward LA, et al
    Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda(-/-) and Ung(-/-) Mice.
    J Immunol. 2018 Jul 6. pii: jimmunol.1700729. doi: 10.4049/jimmunol.1700729.
    PubMed     Abstract available


    March 2018
  23. BELIKAN P, Buhler U, Wolf C, Pramanik GK, et al
    CCR7 on CD4(+) T Cells Plays a Crucial Role in the Induction of Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2018 Mar 16. pii: jimmunol.1701419. doi: 10.4049/jimmunol.1701419.
    PubMed     Abstract available


    January 2018
  24. WILLING A, Jager J, Reinhardt S, Kursawe N, et al
    Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor Expression.
    J Immunol. 2018 Jan 3. pii: jimmunol.1701213. doi: 10.4049/jimmunol.1701213.
    PubMed     Abstract available


    October 2017
  25. SERRE L, Girard M, Ramadan A, Menut P, et al
    Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2017 Oct 23. pii: ji1700667. doi: 10.4049/jimmunol.1700667.
    PubMed     Abstract available


  26. BLANCHFIELD L, Sabatino JJ Jr, Lawrence L, Evavold BD, et al
    NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.
    J Immunol. 2017;199:2680-2691.
    PubMed     Abstract available


  27. MADIREDDI S, Eun SY, Mehta AK, Birta A, et al
    Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.
    J Immunol. 2017;199:2721-2728.
    PubMed     Abstract available


    September 2017
  28. HOSOKAWA T, Kimura T, Nada S, Okuno T, et al
    Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function.
    J Immunol. 2017;199:2008-2019.
    PubMed     Abstract available


    June 2017
  29. LIN CC, Edelson BT
    New Insights into the Role of IL-1beta in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    J Immunol. 2017;198:4553-4560.
    PubMed     Abstract available


  30. SEKI SM, Stevenson M, Rosen AM, Arandjelovic S, et al
    Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
    J Immunol. 2017;198:4607-4617.
    PubMed     Abstract available


  31. MORANDI E, Jagessar SA, 't Hart BA, Gran B, et al
    EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis.
    J Immunol. 2017 Jun 7. pii: ji1700178. doi: 10.4049/jimmunol.1700178.
    PubMed     Abstract available


  32. GIBSON SA, Yang W, Yan Z, Liu Y, et al
    Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
    J Immunol. 2017;198:4244-4254.
    PubMed     Abstract available


    May 2017
  33. HOHLFELD R, Steinman L
    T Cell-Transfer Experimental Autoimmune Encephalomyelitis: Pillar of Multiple Sclerosis and Autoimmunity.
    J Immunol. 2017;198:3381-3383.
    PubMed    


    April 2017
  34. ROTHE T, Ipseiz N, Faas M, Lang S, et al
    The Nuclear Receptor Nr4a1 Acts as a Microglia Rheostat and Serves as a Therapeutic Target in Autoimmune-Driven Central Nervous System Inflammation.
    J Immunol. 2017 Apr 14. pii: 1600638. doi: 10.4049/jimmunol.1600638.
    PubMed     Abstract available


    March 2017
  35. WU Q, Wang Q, Mao G, Dowling CA, et al
    Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    J Immunol. 2017 Mar 3. pii: 1601532. doi: 10.4049/jimmunol.1601532.
    PubMed     Abstract available


    February 2017
  36. LIU R, Ma X, Chen L, Yang Y, et al
    MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by Targeting O-GlcNAc Transferase.
    J Immunol. 2017 Feb 22. pii: 1601727. doi: 10.4049/jimmunol.1601727.
    PubMed     Abstract available


  37. SHIRANI A, Stuve O
    Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology.
    J Immunol. 2017;198:1381-1386.
    PubMed     Abstract available


    January 2017
  38. NEGROTTO L, Correale J
    Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.
    J Immunol. 2017 Jan 27. pii: 1601139. doi: 10.4049/jimmunol.1601139.
    PubMed     Abstract available


    December 2016
  39. LI R, Rezk A, Ghadiri M, Luessi F, et al
    Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    J Immunol. 2016 Dec 14. pii: 1601649.
    PubMed     Abstract available


    November 2016
  40. LOPEZ DE LAPUENTE A, Feliu A, Ugidos N, Mecha M, et al
    Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
    J Immunol. 2016;197:4177.
    PubMed    


  41. CLAES N, Fraussen J, Vanheusden M, Hellings N, et al
    Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients.
    J Immunol. 2016 Nov 11. pii: 1502448.
    PubMed     Abstract available


    October 2016
  42. CHEN D, Ireland SJ, Remington G, Alvarez E, et al
    CD40-Mediated NF-kappaB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
    J Immunol. 2016 Oct 26. pii: 1600782.
    PubMed     Abstract available


  43. HAHN JN, Kaushik DK, Mishra MK, Wang J, et al
    Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
    J Immunol. 2016 Oct 12. pii: 1600436.
    PubMed     Abstract available


    September 2016
  44. WANG D, Ghosh D, Islam SM, Moorman CD, et al
    IFN-beta Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2016 Sep 12. pii: 1500411.
    PubMed     Abstract available


    August 2016
  45. MCARDEL SL, Brown DR, Sobel RA, Sharpe AH, et al
    Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.
    J Immunol. 2016 Aug 31. pii: 1600706.
    PubMed     Abstract available


  46. AGGELAKOPOULOU M, Kourepini E, Paschalidis N, Simoes DC, et al
    ERbeta-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid.
    J Immunol. 2016 Aug 22. pii: 1601038.
    PubMed     Abstract available


    May 2016
  47. AGGELAKOPOULOU M, Kourepini E, Paschalidis N, Panoutsakopoulou V, et al
    ERbeta in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
    J Immunol. 2016 May 13. pii: 1600246.
    PubMed     Abstract available


    April 2016
  48. SHIMOJIMA C, Takeuchi H, Jin S, Parajuli B, et al
    Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2016 Apr 6. pii: 1501457.
    PubMed     Abstract available


    March 2016
  49. GLATIGNY S, Wagner CA, Bettelli E
    Cutting Edge: Integrin alpha4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2016 Mar 25. pii: 1502614.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: